China Medical Technologies reported higher financial results from its first quarter of 2008, which ended on March 31, 2008. Revenues climbed 50% to 227 million RMB ($33.1 million) and non-GAAP net income rose 61% to 111 million RMB ($16.1 million). Earnings per fully diluted ADS were up 49% at 57 cents. Most of the growth came from China Medical's two newest products: the ECLIA and FISH diagnostic systems. More details...

Stock Symbol: (NSDQ: CMED)